Jade Biosciences, Inc. (JBIO)
NASDAQ · Manufacturing · Pharmaceutical preparations
JBIO price, last 12 months
Key stats
- Previous close
- $15.49
- Open
- $15.54
- Day range
- $15.00 – $15.87
- 52-week range
- $11.02 – $28.00
- Volume
- 508.6K
- Avg volume (20 days)
- 875K
- Market cap
- $1.0B
Performance
Technicals and fundamentals
About Jade Biosciences, Inc.
Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy. The company's pipeline also includes JADE201, an afucosylated anti-BAFF-R monoclonal antibody, and JADE301, an antibody candidate in preclinical development.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.0B